The rapid increase in tumor burden upon dual targeting of PD-L1 and TGFβ and the accompanying rise in circulating TGFβ3 generate hypotheses for future study of treatment strategies of colorectal cancer which may be better informed by the observed complexity of potential compensatory signaling of multiple TGFβ isoforms (43–45). The gene discussed is TGFB1; the disease is neoplasm.